Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzia Lotrionte

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Current Opinion in Cardiology|August 2, 2008
The hazards of discontinuing acetylsalicylic acid therapy in those at risk of coronary artery diseaseMarzia Lotrionte, Giuseppe Gl Biondi-Zoccai
World Journal of Cardiology|December 17, 2010
Alternatives to clopidogrel for acute coronary syndromes: Prasugrel or ticagrelor?Giuseppe Biondi-Zoccai, Marzia Lotrionte, Fiorenzo Gaita
American Heart Journal|December 15, 2010
Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplastyGiuseppe Biondi-Zoccai, Marzia Lotrionte, Imad Sheiban
Expert Opinion on Drug Safety|September 2, 2008
Safety of drug-coated stentsGiuseppe Gl Biondi-Zoccai, Claudio Moretti, Marzia Lotrionte, et al.
Giornale Italiano Di Cardiologia (2006)|September 19, 2006
[Pathophysiologic role of myocardial hypertrophy, microcirculatory dysfunction and cardiomyocyte apoptosis in aortic stenosis]Marzia Lotrionte, Leda Galiuto, Giuseppe G L Biondi-Zoccai, et al.
Current Vascular Pharmacology|February 21, 2012
Prasugrel during primary percutaneous coronary intervention: evidence from clinical dataGiuseppe Biondi-Zoccai, Antonio Abbate, Fabrizio D'Ascenzo, et al.
Journal of Thrombosis and Thrombolysis|February 9, 2023
Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular diseaseGabriele Cortellini, Alberto Raiteri, Mattia Galli, et al.
Vascular Health and Risk Management|July 17, 2008
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)Imad Sheiban, Gianluca Villata, Mario Bollati, et al.
Journal of Psychopharmacology (Oxford, England)|December 8, 2009
Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysisMarianna Mazza, Marzia Lotrionte, Giuseppe Biondi-Zoccai, et al.
Progress in Cardiovascular Diseases|February 7, 2016
Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-AnalysisMarzia Lotrionte, Luigi M Biasucci, Mariangela Peruzzi, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Current Opinion in Cardiology|August 2, 2008
The hazards of discontinuing acetylsalicylic acid therapy in those at risk of coronary artery diseaseMarzia Lotrionte, Giuseppe Gl Biondi-Zoccai
World Journal of Cardiology|December 17, 2010
Alternatives to clopidogrel for acute coronary syndromes: Prasugrel or ticagrelor?Giuseppe Biondi-Zoccai, Marzia Lotrionte, Fiorenzo Gaita
American Heart Journal|December 15, 2010
Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplastyGiuseppe Biondi-Zoccai, Marzia Lotrionte, Imad Sheiban
Expert Opinion on Drug Safety|September 2, 2008
Safety of drug-coated stentsGiuseppe Gl Biondi-Zoccai, Claudio Moretti, Marzia Lotrionte, et al.
Giornale Italiano Di Cardiologia (2006)|September 19, 2006
[Pathophysiologic role of myocardial hypertrophy, microcirculatory dysfunction and cardiomyocyte apoptosis in aortic stenosis]Marzia Lotrionte, Leda Galiuto, Giuseppe G L Biondi-Zoccai, et al.
Current Vascular Pharmacology|February 21, 2012
Prasugrel during primary percutaneous coronary intervention: evidence from clinical dataGiuseppe Biondi-Zoccai, Antonio Abbate, Fabrizio D'Ascenzo, et al.
Journal of Thrombosis and Thrombolysis|February 9, 2023
Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular diseaseGabriele Cortellini, Alberto Raiteri, Mattia Galli, et al.
Vascular Health and Risk Management|July 17, 2008
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)Imad Sheiban, Gianluca Villata, Mario Bollati, et al.
Journal of Psychopharmacology (Oxford, England)|December 8, 2009
Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysisMarianna Mazza, Marzia Lotrionte, Giuseppe Biondi-Zoccai, et al.
Progress in Cardiovascular Diseases|February 7, 2016
Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-AnalysisMarzia Lotrionte, Luigi M Biasucci, Mariangela Peruzzi, et al.
Pageof 4